Technology Solutions

goBalto launches study startup solution Select

Thursday, March 31, 2016

goBalto, a provider of cloud-based clinical study startup solutions, has released goBalto Select for optimizing site selection. With this release, goBalto becomes the first life science software vendor to offer a complete end-to-end platform for starting clinical trials, from site feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget.

[Read More]

Certara’s Synchrogenix launches AI transparency solution

Monday, March 28, 2016

Certara, a global biosimulation technology-enabled drug development company, has announced that its regulatory and medical consultancy, Synchrogenix, has introduced an artificial intelligence- (AI-) enabled solution to meet the data transparency requirements of the clinical and drug development market. Those detailed requirements were published by the EMA on March 2 as Policy 70.

[Read More]

Apple to launch new software framework CareKit

Thursday, March 24, 2016

Apple is launching CareKit, a new software framework designed to help developers enable people to actively manage their own medical conditions. iPhone apps using CareKit make it easier for individuals to keep track of care plans and monitor symptoms and medication; providing insights that help people better understand their own health. With the ability to share information with doctors, nurses or family members, CareKit apps help people take a more active role in their health.

[Read More]

Three Questions: Laurence Burke, Exco InTouch

Monday, March 21, 2016

CWWeekly presents this feature as a spotlight on issues that executives in clinical research face. This week, writer Karyn Korieth spoke with Laurence Burke, vice president of Opera­tions, Exco InTouch, which provides digital pa­tient engagement and data capture solutions for clinical research and healthcare providers.

[Read More]

Huawei, WuXi AppTec partner on China Precision Medicine Cloud Platform

Thursday, March 17, 2016

Huawei, a global information and communications technology provider, and WuXi AppTec, a global open-access R&D platform, have announced the signing of a strategic framework agreement to support the China Precision Medicine Initiative (China PMI) through the creation of a state-of the-art precision medicine cloud platform. The agreement builds on Huawei’s capabilities and reach in cloud infrastructure, and the genomics and precision medicine expertise of WuXi NextCODE, the global genomic information and precision medicine subsidiary of WuXi AppTec.

[Read More]

Smartphone app revolutionizes clinical trial consent and data sharing

Monday, March 14, 2016

Sage Bionetworks, a Seattle-based nonprofit, has released the first six months of data from a new iPhone app that captures the everyday experiences of more than 9,500 study participants. The app, called mPower (Mobile Parkinson’s Observatory for Worldwide, Evidence-based Research), manages and simplifies the research study, from patient recruitment through the enrollment and consent process. It also enables researchers to collect extensive data from patients with and without Parkinson’s disease. Data from the study can be used to assess the ability of mobile apps to improve the paradigm for clinical studies.

[Read More]

Exco InTouch, Oracle Health Sciences partner on EDC/ePRO system

Tuesday, March 8, 2016

Exco InTouch, a provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, and Oracle Health Sciences have partnered to launch a standardized integration between two “best of breed” solutions to provide a robust, highly integrated electronic data capture (EDC) and electronic patient reported outcomes (ePRO) solution which provides the market with a resource that streamlines workflow processes in clinical research.   

[Read More]

IBM, New York Genome Center partner on open cancer data repository

Monday, March 7, 2016

The New York Genome Center and IBM are collaborating to create a comprehensive and open repository of genetic data to accelerate cancer research and scale access to precision medicine using cognitive insights from IBM Watson. Analyzing this data alongside the medical community’s growing knowledge about cancer could help accelerate the ability of doctors to deliver personalized treatment to individual patients.

[Read More]